Literature DB >> 17574401

Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.

Markus Vogt1, Klaus Kunath, Jennifer B Dressman.   

Abstract

The rate of the dissolution of four poorly soluble drugs (EMD 57033, albendazole, danazol and felodipine) was improved by cogrinding them with various excipients (lactose monohydrate, corn starch, polyvinylpyrrolidone, hydroxypropylmethyl cellulose and sodium lauryl sulphate) using a jet-milling technique. Solid state characterization studies by X-ray diffraction and differential scanning calorimetry verified the maintenance of the crystalline state of the active substances after milling. In vitro dissolution of the coground mixtures in biorelevant media was much faster than from micronised drug in the corresponding physical mixtures for all four compounds. Supersaturated solutions were generated in some cases (EMD 50733 and felodipine), but this phenomenon appeared to be drug- and excipient-specific. Cogrinding with lactose monohydrate resulted in fast dissolution with unstable supersaturation for EMD 57033. Cogrinding the same drug with PVP or HPMC produced a more sustained supersaturation. SLS accelerated the dissolution of EMD 50733 but inhibited supersaturation. The results suggest that the cogrinding with selected excipients is a powerful tool to accelerate the dissolution of poorly soluble drugs without converting the drug to the amorphous form or changing the particle size.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574401     DOI: 10.1016/j.ejpb.2007.05.009

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  11 in total

1.  Cogrinding as a tool to produce sustained release behavior for theophylline particles containing magnesium stearate.

Authors:  Ali Nokhodchi; Ononuju N Okwudarue; Hadi Valizadeh; Mohammad N Momin
Journal:  AAPS PharmSciTech       Date:  2009-10-28       Impact factor: 3.246

2.  Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.

Authors:  Nadia Bou-Chacra; Katherine Jasmine Curo Melo; Ivan Andrés Cordova Morales; Erika S Stippler; Filippos Kesisoglou; Mehran Yazdanian; Raimar Löbenberg
Journal:  AAPS J       Date:  2017-05-17       Impact factor: 4.009

3.  Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Authors:  Emad B Basalious; Wessam El-Sebaie; Omaima El-Gazayerly
Journal:  AAPS PharmSciTech       Date:  2011-06-24       Impact factor: 3.246

4.  NanoClusters surface area allows nanoparticle dissolution with microparticle properties.

Authors:  Christopher Kuehl; Nashwa El-Gendy; Cory Berkland
Journal:  J Pharm Sci       Date:  2014-04-30       Impact factor: 3.534

5.  Improved albendazole dissolution rate in pluronic 188 solid dispersions.

Authors:  Silvina G Castro; Sergio Sanchez Bruni; Carlos E Lanusse; Daniel A Allemandi; Santiago D Palma
Journal:  AAPS PharmSciTech       Date:  2010-10-14       Impact factor: 3.246

6.  Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR.

Authors:  Takeshi Io; Toshiro Fukami; Kazutoshi Yamamoto; Toyofumi Suzuki; Jiadi Xu; Kazuo Tomono; Ayyalusamy Ramamoorthy
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

7.  Dissolution enhancement of chlorzoxazone using cogrinding technique.

Authors:  Mihir K Raval; Jaydeep M Patel; Rajesh K Parikh; Navin R Sheth
Journal:  Int J Pharm Investig       Date:  2015 Oct-Dec

8.  Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization.

Authors:  Naveen Kanthamneni; Satyanarayana Valiveti; Mita Patel; Heather Xia; Yin-Chao Tseng
Journal:  Int J Pharm Investig       Date:  2016 Oct-Dec

9.  Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement.

Authors:  Bhavesh D Kevadiya; Manish Barvaliya; Lu Zhang; Ashish Anovadiya; Harshad Brahmbhatt; Parimal Paul; Chandrabhanu Tripathi
Journal:  Bioengineering (Basel)       Date:  2018-02-13

Review 10.  Intestinal lymphatic transport for drug delivery.

Authors:  Jaime A Yáñez; Stephen W J Wang; Ian W Knemeyer; Mark A Wirth; Kevin B Alton
Journal:  Adv Drug Deliv Rev       Date:  2011-06-13       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.